New migraine pill NURTEC tested on 3,000 koreans for safety and relief
NCT ID NCT07497854
First seen Apr 19, 2026 · Last updated May 23, 2026 · Updated 5 times
Summary
This study will monitor 3,000 adults in Korea who take NURTEC ODT 75 mg for migraines, either to stop an attack or prevent future ones. Researchers will track side effects and how well the drug works, like whether it makes pain go away within 2 hours. The goal is to confirm the drug's safety and effectiveness in real-world use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE WITH OR WITHOUT AURA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.